{"news_desk": "Editorial", "print_page": "18", "section_name": "Opinion", "subsection_name": null, "byline": {"contributor": "", "original": "By THE EDITORIAL BOARD", "person": [], "organization": "THE EDITORIAL BOARD"}, "abstract": "Editorial criticizes Food and Drug Administration for its lethargic regulation of dietary supplements containing dangerous stimulant BMPEA; contends agency has been compromised by too many officials with strong ties to industry in key positions; calls on Congress to enact conflict-of-interest laws that would limit officials from acting in cases related to former employment.", "type_of_material": "Editorial", "word_count": "533", "lead_paragraph": "Industry insiders within the agency have too much say in regulating dietary supplements.", "pub_date": "2015-04-13T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Conflicts of Interest at the F.D.A.", "content_kicker": "Editorial", "print_headline": "Conflicts of Interest at the F.D.A.", "kicker": "Editorial"}, "snippet": "Industry insiders within the agency have too much say in regulating dietary supplements.", "multimedia": [{"height": 126, "url": "images/2015/04/13/opinion/13mon2web/13mon2web-thumbWide.jpg", "legacy": {"widewidth": "190", "wideheight": "126", "wide": "images/2015/04/13/opinion/13mon2web/13mon2web-thumbWide.jpg"}, "type": "image", "width": 190, "subtype": "wide"}, {"height": 429, "url": "images/2015/04/13/opinion/13mon2web/13mon2web-articleLarge.jpg", "legacy": {"xlargewidth": "600", "xlargeheight": "429", "xlarge": "images/2015/04/13/opinion/13mon2web/13mon2web-articleLarge.jpg"}, "type": "image", "width": 600, "subtype": "xlarge"}, {"height": 75, "url": "images/2015/04/13/opinion/13mon2web/13mon2web-thumbStandard.jpg", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2015/04/13/opinion/13mon2web/13mon2web-thumbStandard.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "subtype": "thumbnail"}], "web_url": "http://www.nytimes.com/2015/04/13/opinion/conflicts-of-interest-at-the-fda.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Editorials", "name": "subject"}, {"rank": "2", "is_major": "Y", "value": "Food and Drug Administration", "name": "organizations"}, {"rank": "3", "is_major": "Y", "value": "Conflicts of Interest", "name": "subject"}, {"rank": "4", "is_major": "N", "value": "Amphetamines", "name": "subject"}, {"rank": "5", "is_major": "N", "value": "Regulation and Deregulation of Industry", "name": "subject"}, {"rank": "6", "is_major": "N", "value": "Recalls and Bans of Products", "name": "subject"}, {"rank": "7", "is_major": "N", "value": "Fabricant, Daniel (1975- )", "name": "persons"}, {"rank": "8", "is_major": "N", "value": "Welch, Cara R (1980- )", "name": "persons"}, {"rank": "9", "is_major": "Y", "value": "Dietary Supplements and Herbal Remedies", "name": "subject"}], "blog": [], "_id": "552b6e6438f0d824bd2ecdf3", "source": "The New York Times"}